Market News Archives

Insulin Pumps Have a Moment: Why Insulet Is Growing Like a Tech Stock, Not a Medical Device -( $PODD $TNDM $MODD )

by John F. Heerdink, Jr. March 4, 2026 539Views 0Likes

Insulin pumps are having a moment, and this time it is not just Wall Street that is impressed—it is patients, payers, and, increasingly, competitors playing catch‑up. Insulet’s Growth Streak Enters Double Digits Insulet (PODD) closed 2025 like a company that never got…

March 4, 2026 – Markets Hold Their Nerve: Iran Blinks, Bitcoin Winks, and Bulls Tiptoe Back In -( $ASNS $BTC $DV $EPRX $FIGS $GOVX $INTG $MODD $MRNA $NOK $NVDA Rise!)

by John F. Heerdink, Jr. March 4, 2026 1904Views 0Likes

US stocks rebounded on Wednesday, March 4, 2026, as easing fears around the Iran conflict and steadier oil prices helped buyers step back in, while Bitcoin extended its latest surge. Index performance The major US benchmarks climbed, recapturing a chunk of the…

Intel’s Quiet Comeback: How a Boring Old Chip Giant Crashed the AI Party -( $INTC $MS $SPY )

by John F. Heerdink, Jr. March 4, 2026 392Views 0Likes

Intel (INTC) is trying very hard to make “old-school silicon” sound like the hottest asset class in town—and, judging from its latest press run, the company may be getting somewhere. A Boardroom Tune-Up for the AI PC Era Intel’s most recent headline…

Actelis Catches the Green Light: Caltrans Deal Puts a Little Company in California’s Fast Lane -( $ASNS)

by John F. Heerdink, Jr. March 4, 2026 619Views 0Likes

Actelis Networks (NASDAQ: ASNS) is hardly a household name, but in California’s latest highway overhaul, the quiet specialist in hybrid fiber-copper networking just got the green light in a big way. The company has landed an order from the California Department of Transportation (Caltrans)…

From Walled Gardens to Open Books: How DoubleVerify Makes Ad Tech Act Its Age-( $DV $SPY )

by John F. Heerdink, Jr. March 4, 2026 446Views 0Likes

DoubleVerify (NYSE: DV) has spent the opening months of 2026 behaving less like an ad-tech vendor and more like a company intent on rewriting the operating manual for digital media trust. Streaming TV Grows Up: DV’s CES Moment At CES 2026, DoubleVerify…

Genevant, Arbutus and Moderna: How a Once-in-a-Lifetime Pandemic Ended With a Once-in-a-Lifetime Check -( $MRNA $ABUS )

by John F. Heerdink, Jr. March 4, 2026 679Views 0Likes

In the end, it was not a jury but a checkbook that settled one of biotech’s more closely watched intellectual-property dramas. Moderna will pay up to 2.25 billion dollars to Genevant Sciences and Arbutus Biopharma to resolve a global web of patent…

From Wires to Wizards: How Nokia Is Teaching Networks to Code Themselves -( $GOOG $NOK $VOD )

by John F. Heerdink, Jr. March 3, 2026 410Views 0Likes

Nokia's (NOK) Network as Code platform is gaining global momentum, drawing major telecom giants into a collaborative ecosystem that promises to revolutionize programmable connectivity. With fresh partnerships and AI integrations, the Finnish telecom leader is scripting a narrative of innovation that's as…

Missiles and Microchips: Why Mobix Labs Just Became Wall Street’s New Crush -( $MOBX )

by John F. Heerdink, Jr. March 3, 2026 506Views 0Likes

Mobix Labs (NASDAQ, MOBX) has quietly slipped a critical piece of technology into one of the U.S. Navy’s most visible weapons systems—and investors just noticed. A fresh production order tied to the Tomahawk cruise missile program has turned this fabless RF specialist…

March 3, 2026 – Oil Shock and War Fears Rattle Wall Street: Major Indexes Slide Despite Late Comeback -( $ASTS $GOVX $KTB $INTA $INTM $MOBX $MODD $SOAR Rise!)

by John F. Heerdink, Jr. March 3, 2026 1717Views 0Likes

US stocks fell sharply Tuesday but closed well off their intraday lows as investors weighed an escalating war in Iran, a spike in oil, and the risk of stickier inflation. The Dow, S&P 500, and Nasdaq all finished lower for a second…

Modular Medical’s $12 Million Shot in the Arm: Can a Tiny Pump Make a Big Splash in Diabetes Care? -( $MODD $MDT $PODD $TNDM )

by John F. Heerdink, Jr. March 3, 2026 521Views 0Likes

Modular Medical’s (NASDAQ: MODD) latest capital raise seems to read less like a distress flare and more like a carefully aimed flare gun over the diabetes device market, signaling that the small-cap insurgent still plans to play big-league offense in insulin delivery…

Market News

Your Guide To Staying Informed In The Markets